EXPLORE MRace (GE): Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Mitral Regurgitation Using the MRace Implant

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT07796659

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Polares Medical SA (from the registry)
Registry
  • NCT NCT07796659
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Georgia (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07796659. Allocation not applicable; no masking; primary purpose treatment. Start 2022-05-23 (actual); primary completion 2032-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
EXPLORE MRace (GE): Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Mitral Regurgitation Using the MRace Implant
Acronym
EXPLORE_MRace
Condition
Mitral Valve Disease
Intervention (Device)
Transcatheter mitral valve repair (MRace Implant and Delivery System)
Lead sponsor
Polares Medical SA (class: industry)

Record details

Record id
cardio:ct-nct07796659
Content hash
006c0d6c5f1801e884e0ecb101be691412832d91759a083a0f86a535dceeb036